Keeping up with scientific advances and practice changes can be one the biggest challenges in managing a complex disease like multiple sclerosis (MS).

As global markets navigate a tumultuous landscape marked by escalating trade tensions and fluctuating consumer sentiment, the tech sector remains a focal point for investors seeking growth ...

Report Ocean published the latest research report on the Surface Treatment Chemicals Market. In order to comprehend a market holistically, a variety of factors must be evaluated, including ...

This treatment modality is particularly effective for blood cancers and has the potential to transform the treatment landscape for other types of cancer. Additionally, the rise of gene therapies and ...

Equity, sustainability, and innovation must go hand in hand for the MM treatment landscape to truly evolve. 1. Pasvolsky O, Wang Z, Milton DR, et al. Multiple myeloma patients with a long ...

Natural Falls State Park in Colcord, Oklahoma is the reset button you didn’t know you needed. Tucked away in the northeastern corner of Oklahoma, this 120-acre slice of paradise feels like Mother ...

This positions Akeso as a key innovator in next-generation cancer immunotherapy, improving and contributing to the global IO cancer treatment landscape. Breakthrough Bispecifics Enter NRDL, Paving the ...

Stay up to date on recent advances in oncology nursing and patient care.

This positions Akeso as a key innovator in next-generation cancer immunotherapy, improving and contributing to the global IO cancer treatment landscape. Breakthrough Bispecifics Enter NRDL ...

AK117 (CD47) enters Phase III trials: ivonescimab combined with AK117 for first-line HNSCC treatment, compared with pembrolizumab. Cadonilimab and ivonescimab: Over 20 Phase III and 40+ Phase II ...